WHO wants faster, more flu vaccine production

Sep 06, 2010 By MIN LEE , Associated Press Writer

(AP) -- The vaccine used to contain the recent swine flu pandemic was effective, but health authorities will need to ramp up the speed and volume of production during the next global outbreak, a World Health Organization official said Monday.

The WHO declared last month that the swine flu pandemic that started in June 2009 was over, after it killed about 18,600 people worldwide, far less than the worse-case scenarios in which authorities said millions could die.

The widespread use of vaccines was critical in limiting the number of casualties, with studies showing they offered protection in up to 95 percent of cases, WHO official David Wood said at a news conference on the sidelines of an influenza conference in Hong Kong.

Some 350 million doses of the were administered worldwide, according to WHO figures.

"That gives us considerable hope for the future, for the future , that the technologies that we have to actually make the vaccines are" effective, said Wood, the quality and safety team co-ordinator for the WHO's immunization and vaccines department.

But while vaccines became available six months after the H1N1 behind the pandemic was identified in April 2009, that was still too late for some countries, he said. In the case of the U.S., vaccination started on Oct. 5, 2009 - weeks after a second wave of cases hit as schools resumed, U.S. flu expert Nancy Cox told reporters.

The WHO is studying ways to make vaccines more quickly, Wood said without offering specifics, adding that technological breakthroughs will also speed up the process.

"In the short term, we'll be able to make some gains of weeks that Nancy was talking about that can make all the difference. In the longer term, we may even have these new technologies that shorten our lag more significantly, so I'm quite optimistic," Wood said.

The WHO official also said the global healthy body is working on increasing global production capacity beyond the centers of Europe, America and China, targeting countries like India, Indonesia, Thailand, Brazil and Mexico.

The WHO was accused by some of hyping the pandemic, prompting excessive buying of vaccines and antiviral drugs that enriched drug companies. Asked about such accusations, Wood said the organization only advised countries to vaccinate high-risk groups, like health care workers and pregnant women.

"I believe that the recommendations that came from the organization were proportionate to the risks that we had at the time," he said.

Explore further: FDA OKs Cubist antibiotic for serious infections

not rated yet
add to favorites email to friend print save as pdf

Related Stories

WHO meets on production of swine flu vaccine

May 14, 2009

(AP) -- As swine flu cases hit 6,500 worldwide, World Health Organization officials were meeting with vaccine manufacturers and other experts in Geneva on Thursday to discuss making a vaccine to fight the virus.

Expert warns of complacency after swine flu fizzle

Sep 05, 2010

(AP) -- A leading virus expert urged health authorities around the world Sunday to stay vigilant even though the recent swine flu pandemic was less deadly than expected, warning that bird flu could spark ...

WHO chief: swine flu pandemic continues

Dec 29, 2009

(AP) -- Many more people could become sick with swine flu this winter even though it has peaked in North America and some European countries, the head of the World Health Organization said Tuesday.

Recommended for you

FDA OKs Cubist antibiotic for serious infections

Dec 20, 2014

The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved since May.

Xtoro approved for swimmer's ear

Dec 18, 2014

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

Drug interaction identified for ondansetron, tramadol

Dec 18, 2014

(HealthDay)—In the early postoperative period, ondansetron is associated with increased requirements for tramadol consumption, according to a review and meta-analysis published online Dec. 10 in Anaesthesia.

New system targets germs in donated blood plasma

Dec 17, 2014

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.